CLOPIDOGREL ASPIRIN in pharma franchise in Bihar

CLOPIDOGREL ASPIRIN in PCD pharma franchise in Aizawl

CLOPIDOGREL ASPIRIN in top pharma company in Aizawl

CLOPIDOGREL ASPIRIN in pcd pharma supplier in Bhilai

CLOPIDOGREL ASPIRIN in phama franchise company in india
CLOPIDOGREL ASPIRIN phama distributor in Ludhiana

Home/Products /clopidogrel-75-mg-aspirin-150-mg-tablet

Clopiside A 150 Tablet

Composition : Clopidogrel 75mg + Aspirin 150mg Tablet

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*15

Price : ₹45/-

Clopidile A150 Tablet is a combination of Clopidogrel and Aspirin, both powerful antiplatelet agents that help prevent blood clot formation in patients at high risk of cardiovascular diseases. This medication is commonly prescribed to reduce the risk of heart attacks, strokes, and other clot-related complications, especially in individuals with coronary artery disease (CAD), peripheral artery disease (PAD), or those who have undergone angioplasty or stent placement.

Clopidogrel works by inhibiting platelet aggregation, preventing the formation of harmful clots in blood vessels. Aspirin complements this action by blocking thromboxane A2, further reducing the risk of arterial blockages. Together, they provide enhanced protection against cardiovascular complications.

This combination is widely used in dual antiplatelet therapy (DAPT), ensuring better blood circulation and reducing the chances of recurrent heart-related issues. It is essential to take this medication as prescribed and avoid sudden discontinuation without medical advice.

Read More

About the Product

Clopidile A150 Tablet is a combination of Clopidogrel and Aspirin, both powerful antiplatelet agents that help prevent blood clot formation in patients at high risk of cardiovascular diseases. This medication is commonly prescribed to reduce the risk of heart attacks, strokes, and other clot-related complications, especially in individuals with coronary artery disease (CAD), peripheral artery disease (PAD), or those who have undergone angioplasty or stent placement.

Clopidogrel works by inhibiting platelet aggregation, preventing the formation of harmful clots in blood vessels. Aspirin complements this action by blocking thromboxane A2, further reducing the risk of arterial blockages. Together, they provide enhanced protection against cardiovascular complications.

This combination is widely used in dual antiplatelet therapy (DAPT), ensuring better blood circulation and reducing the chances of recurrent heart-related issues. It is essential to take this medication as prescribed and avoid sudden discontinuation without medical advice.

May cause nausea, stomach pain, dizziness, indigestion, bruising, or minor bleeding. Serious side effects like severe bleeding or gastrointestinal ulcers are rare but require immediate medical attention.

Prevention of heart attacks, strokes, and blood clot-related conditions in patients with cardiovascular diseases, especially after angioplasty or stent placement.

Avoid use if you have a bleeding disorder, active ulcers, or a history of severe aspirin allergy. Consult a doctor before taking it with other blood thinners or NSAIDs. Regular monitoring may be required for long-term use.

Store in a cool, dry place, away from moisture and sunlight. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation